Peer Review reports
From: miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1
| Original Submission | ||
|---|---|---|
| 7 Jan 2020 | Submitted | Original manuscript |
| 20 Feb 2020 | Reviewed | Reviewer Report |
| 17 Mar 2020 | Reviewed | Reviewer Report - Zhengyu Zha |
| 31 Mar 2020 | Reviewed | Reviewer Report - Jiping Zeng |
| 5 Jun 2020 | Author responded | Author comments - Yang Meng |
| Resubmission - Version 2 | ||
| 5 Jun 2020 | Submitted | Manuscript version 2 |
| 3 Aug 2020 | Reviewed | Reviewer Report |
| 11 Sep 2020 | Reviewed | Reviewer Report |
| 26 Sep 2020 | Author responded | Author comments - Yang Meng |
| Resubmission - Version 3 | ||
| 26 Sep 2020 | Submitted | Manuscript version 3 |
| Publishing | ||
| 29 Sep 2020 | Editorially accepted | |
| 27 Oct 2020 | Article published | 10.1186/s12885-020-07472-2 |
You can find further information about peer review here.